Call Our HELPLINE: 1-800-4PD-INFO (473-4636)

National Parkinson Foundation (NPF) and the Parkinson’s Disease Foundation (PDF) Complete Merger to Form the Parkinson’s Foundation

New York and Miami, August 1, 2016—The Boards of Directors of the National Parkinson Foundation (NPF) and the Parkinson's Disease Foundation (PDF) announced today that they have finalized the merger of the two non-profit organizations. The organization will operate as the Parkinson's Foundation with offices in New York City and Miami.

"This merger is about the future and we are thrilled to have it completed," said John Kozyak, Board Chair of the Parkinson's Foundation.  "Millions of people worldwide are living with Parkinson's. We owe it to them to move the science and care forward and the merger allows us to do just that even better. We are driven by the perspective, needs and priorities of people living with the disease and, together, we will be a formidable and effective force in the fight against Parkinson's."  

The Parkinson's Foundation will be governed by a Board of Directors that will include 11 members from each of the legacy organizations. Mr. Kozyak, who was formerly Chair of NPF, will serve as Board Chair for two years, to be succeeded by Howard Morgan, formerly Chair of PDF. Mr. Morgan will initially serve as Vice Chair of the Parkinson's Foundation.

"The Parkinson's Foundation will be greater than the sum of our individual parts. Indeed, the coming together has redoubled our shared spirit of focus and purpose. And that is just the beginning," said Mr. Morgan. "The merger presents extraordinary opportunities for the future, but rest assured, we are also very focused on the present.  While we do not anticipate any changes to our exceptional programs — from our Centers of Excellence and individual and collaborative research and training programs around the world to our helpline services and education and advocacy programs in communities across the country — we embrace the opportunity of integrating the two organizations as an occasion for renewed commitment."

A Search Committee of the Board has been formed to recruit a dynamic new Chief Executive Officer for the organization. The executive search firm of Russell Reynolds has been retained to assist in this effort. Each division will continue to communicate with its supporters under its legacy brand until the Parkinson's Foundation brand is fully integrated. 

The Parkinson's Foundation Board of Directors includes the following individuals:

John Kozyak, Esq. – Chair
Founding partner of Kozyak Tropin & Throckmorton
Miami, Florida

Howard Morgan Vice Chair
Partner and Senior Managing Director, Argand Partners
New York, New York

Stephen AckermanAssistant Treasurer
Executive Director, Morgan Stanley Wealth Management
New York, New York

Andrew AlbertChair of Nominating and Governance Committee
Managing Director and Operating Partner of Svoboda Capital Partners, LLC
Chicago, Illinois

Constance Woodruff Atwell, Ph.D. Interim Chair of the Scientific Advisory Committee
Former Director of the Division of Extramural Research at NIH/NINDS
Pinehurst, North Carolina

J. Gordon Beckham, Jr.
President and CEO of InfoSys McCamish Systems, LLC
Atlanta, Georgia

Marshall Burack, Esq.— Assistant Secretary
Partner at Kopelowitz Ostrow Ferguson Weiselberg
Miami, Florida

Karen Elizabeth Burke, M.D., Ph.D.
Dermatologist and research scientist on the faculties of Mt. Sinai Medical Center and Cabrini Medical Center
New York, New York

Alessandro Di Rocco, M.D.
Founders Professor of Neurology and Chief, Division of Movement Disorders, Director, The Marlene and Paolo Fresco Institute for Parkinson's and Movement Disorders, (a National Parkinson Foundation Center of Excellence) NYU Langone Medical Center
New York, New York

Alberto Dosal – Treasurer
Chairman and CEO of Dosal Capital
Miami, Florida

G. Pennington Egbert IIIChair of the Development Committee
Managing Director, Head of Global Markets Research, Americas at Nomura Securities International
New York, New York

Stanley Fahn, M.D.
H. Houston Merritt Professor of Neurology and Director Emeritus, Division of Movement Disorders, Department of Neurology at the PDF Research Center at Columbia University Medical Center
New York, New York

Richard Field
Co-Founder of Lending Tree, LLC
New Canaan, Connecticut

Guido Goldman, Ph.D.
Director of the Program for the Study of Germany at the Minda de Gunzburg Center for European Studies of Harvard University
Miami, Florida

Stephanie Goldman
Incoming President of the Jewish Federation of Northern New Jersey and member of the Board of Lighthouse International
Norwood, New Jersey

Arlene Levine
Chair of the Fund for Women and Girls Philanthropic Breakfast of the New York Community Trust of Westchester County
Scarsdale, New York

Mindy McIlroy
Executive Vice President of Terranova Corporation
Miami, Florida

Robert Melzer
Former President and CEO of Property Capital Trust, Boston and former Chair of the Board of Directors, Beth Israel Deaconess Medical Center, Boston
Boston, Massachusetts

Gail Milhous
Private philanthropist and community activist
Boca Raton, Florida

Michael S. Okun, M.D.
Adelaide Lackner Professor and Chairman of Neurology, University of Florida
Co-Director UF Center for Movement Disorders and Neurorestoration
Gainesville, Florida

Timothy A. Pedley, M.D.
Henry and Lucy Moses Professor of Neurology at Columbia University and past President of the American Academy of Neurology
New York, New York

Gregory Romero Secretary
Vice President of KE Tube, Inc.
Gardner, Massachusetts

About the Parkinson's Foundation
The Parkinson's Foundation is working toward a world without Parkinson's disease. Formed by the merger of National Parkinson Foundation (NPF) and the Parkinson's Disease Foundation (PDF) in August 2016, the mission of the Parkinson's Foundation is to invest in promising scientific research that will end Parkinson's disease and improve the lives of people with Parkinson's, and their families, through improved treatments, support and the best care. For more information, visit www.parkinson.org or call (800) 4PD-INFO (473-4636).

About Parkinson's Disease (PD)
Parkinson's disease is a progressive neurological disorder that affects nearly one million people in the US and over 10 million worldwide.  Parkinson's is the second most common neurodegenerative disease after Alzheimer's and is the 14th leading cause of death in the US.  It is associated with a loss of motor control (e.g., shaking or tremor at rest and lack of facial expression) as well as non-motor symptoms (e.g., depression A mood disorder whose symptoms can include a persistent sad or empty mood, feelings of hopelessness or pessimism, irritability and loss of interest or pleasure in previously enjoyable activities. and anxiety A feeling of nervousness, worried thoughts and physical distress.).  Although promising research is being conducted, there is currently no cure for Parkinson's disease.

Monday, August 1, 2016
New Study Shows 1.2 Million People in the United States Estimated to be Living with Parkinson’s Disease by 2030
Tuesday, July 10, 2018

Parkinson’s Foundation Reveals Most Comprehensive Estimate of
Parkinson’s Prevalence in North America since the 1970’s

Parkinson’s Foundation Elects Howard D. Morgan Chairman of the Board
Tuesday, June 26, 2018

MIAMI & NEW YORK — June 26, 2018 — The Parkinson’s Foundation today announced the election of Howard D. Morgan as chairman of its board of directors. Mr. Morgan, who previously served as the Vice Chair of the nonprofit organization’s board, is a Partner and the Senior Managing Director of Argand Partners in New York.

Parkinson’s Foundation Announces Five New Members of its People with Parkinson’s Advisory Council
Wednesday, June 13, 2018

NEW YORK & MIAMI — June 13, 2018 — The Parkinson’s Foundation today announced five new members of its People with Parkinson’s Advisory Council.

The Parkinson’s Foundation 2018 Gala in New York City Tuesday, May 8, 2018
Monday, May 14, 2018

The Parkinson’s Foundation 2018 Gala was held at Cipriani 25 Broadway in New York City on Tuesday, May 8, 2018.

Parkinson’s Foundation Adds Alison Herman to its Board of Directors
Tuesday, May 8, 2018

MIAMI – May 9, 2018 – The Parkinson’s Foundation today announced the election of Alison Herman to its board of directors. Herman is senior counsel at Southern Glazer’s Wine & Spirits, a company which has generously supported Parkinson’s Foundation fundraisers.

Statement on Nuplazid Drug
Tuesday, April 10, 2018

On 4/9/18, CNN published an article on the FDA-approved drug, Nuplazid, used to treat hallucinations and psychosis in Parkinson’s disease. The article investigates FDA data showing the number of reported deaths with people taking Nuplazid. Nuplazid was approved by the FDA in 2016 and is manufactured by Acadia Pharmaceuticals.

Parkinson’s Foundation Adds John D. Thomopoulos to its Board of Directors
Monday, March 19, 2018

MIAMI & NEW YORK – March 19, 2018 – The Parkinson’s Foundation today announced the election of John D. Thomopoulos to its board of directors. Thomopoulos is a partner at Ernst & Young.

In Memory of Edythe Kay Marsa
Monday, March 12, 2018

The Parkinson’s Foundation mourns the loss of emeritus board member, Edythe (Edy) Kay Marsa. From 1993 to 2014, she was a member of the Foundation’s board of directors and served on several committees. Edy is survived by her husband William Marsa, who founded the Herbert Kay Parkinson Chapter in honor of her first husband who passed away due to complications from Parkinson’s disease.

Parkinson’s Foundation Announces New Genetic Initiative Connecting Parkinson’s Genetic Data with Clinical Care
Tuesday, March 6, 2018

MIAMI & NEW YORK—March 6, 2018—The Parkinson’s Foundation today announced a new initiative offering genetic testing and counseling to Parkinson’s patients within its Center of Excellence network.

Delegates From The Parkinson’s Community Converge On Capitol Hill To Advocate For Critical Research Funding
Monday, March 5, 2018

—2018 Parkinson’s Policy Forum Co-Sponsored by the Parkinson’s Foundation and the Michael J. Fox Foundation for Parkinson’s Research—

Pages

mail icon

Subscribe to get the latest news on treatments, research and other updates.